Investing
Investing Cash Flow
Bristol-Myers Squibb Investing Cash Flow increased by 91.0% to -$131.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 73.7%, from -$499.00M to -$131.00M. Over 2 years (FY 2023 to FY 2025), Investing Cash Flow shows a downward trend with a 34.2% CAGR.
Analysis
StatementCash Flow Statement
SectionInvesting
CategoryCapital Allocation
SignalContext dependent
VolatilityModerate
First reportedQ1 2013
Last reportedQ1 2026Apr 30, 2026
How to read this metric
A negative value typically signals investment in future growth, while a positive value may indicate divestment or the maturity of a large investment portfolio.
Detailed definition
This metric is the net total of all cash inflows and outflows related to investing activities, including capital expendi...
Peer comparison
Most mature healthcare companies maintain a negative net investing cash flow due to ongoing R&D and infrastructure investment.
Metric ID:
net_cash_from_investingHistorical Data
18 periods
| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $180.00M | -$976.00M | $95.00M | -$289.00M | -$2.08B | -$210.00M | -$329.00M | -$410.00M | -$1.35B | -$19.62B | -$1.32B | -$219.00M | -$196.00M | -$499.00M | -$473.00M | -$1.70B | -$1.46B | -$131.00M |
| QoQ Change | — | -642.2% | +109.7% | -404.2% | -620.1% | +89.9% | -56.7% | -24.6% | -228.3% | <-999% | +93.3% | +83.4% | +10.5% | -154.6% | +5.2% | -259.8% | +14.3% | +91.0% |
| YoY Change | — | — | — | -260.6% | -113.2% | -321.1% | -13.8% | +80.3% | — | <-999% | -300.9% | +46.6% | +85.4% | +97.5% | +64.1% | -677.2% | -643.9% | +73.7% |
Range-$19.62B – $180.00M
CAGR-7.2%
Avg YoY Growth-794.6%
Median YoY Growth-63.5%
Current Streak2 quarters growth
Investing Cash Flow at Other Companies
Frequently Asked Questions
- What is Bristol-Myers Squibb's investing cash flow?
- Bristol-Myers Squibb (BMY) reported investing cash flow of -$131.00M in Q1 2026.
- How has Bristol-Myers Squibb's investing cash flow changed year-over-year?
- Bristol-Myers Squibb's investing cash flow increased by 73.7% year-over-year, from -$499.00M to -$131.00M.
- What is the long-term trend for Bristol-Myers Squibb's investing cash flow?
- Over 2 years (2023 to 2025), Bristol-Myers Squibb's investing cash flow has grown at a 34.2% compound annual growth rate (CAGR), from -$2.30B to -$4.13B.
- What does investing cash flow mean?
- The net amount of cash spent on or received from investing activities.